Relay Therapeutics
Melvin Makil, PharmD, MBA, BCMAS, RPh, serves as the Regional Director of Medical Affairs for Hematology Oncology and Rare Diseases at Relay Therapeutics since August 2022. Prior experience includes senior and director roles in hematology oncology rare disease medical science liaison positions at Epizyme, and a medical science liaison role at Acrotech Biopharma, LLC. Melvin also contributed as a Clinical Hematology and Oncology Pharmacist at Robert Wood Johnson University Hospital and as a Clinical Research Pharmacist at Rutgers Robert Wood Johnson Medical School. Earlier career roles included pharmacy intern positions across various healthcare settings and externships in community and hospital practices. Melvin holds a Doctor of Pharmacy degree from Rutgers University and an MBA from Rutgers Business School.
This person is not in any teams
This person is not in any offices
Relay Therapeutics
2 followers
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology.